Citation: Xiaoxiao Wang, Bolun Wang, Fenfen Ji, Jie Yan, Jiacheng Fang, Doudou Zhang, Ji Xu, Jing Ji, Xinran Hao, Hemi Luan, Yanjun Hong, Shulan Qiu, Min Li, Zhu Yang, Wenlan Liu, Xiaodong Cai, Zongwei Cai. Discovery of plasma biomarkers for Parkinson’s disease diagnoses based on metabolomics and lipidomics[J]. Chinese Chemical Letters, ;2024, 35(11): 109653. doi: 10.1016/j.cclet.2024.109653 shu

Discovery of plasma biomarkers for Parkinson’s disease diagnoses based on metabolomics and lipidomics

Xiaoxiao Wang ^{a, 1} ,
Bolun Wang ^{a, 1} ,
Fenfen Ji ^a ,
Jie Yan ^b ,
Jiacheng Fang ^a ,
Doudou Zhang ^b ,
Ji Xu ^c ,
Jing Ji ^c ,
Xinran Hao ^a ,
Hemi Luan ^a ,
Yanjun Hong ^a ,
Shulan Qiu ^a ,
Min Li ^d ,
Zhu Yang ^{a, *,} ,
Wenlan Liu ^{c, *,} ,
Xiaodong Cai ^{b, *,} ,
Zongwei Cai ^{a, *,}

a.
State Key Laboratory of Environmental and Biological Analysis, Department of Chemistry, Hong Kong Baptist University, Hong Kong, China
b.
Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen 518035, China
c.
The Central Laboratory, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen 518035, China
d.
Mr. and Mrs. Ko Chi Ming Centre for Parkinson’s Disease Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China

Received Date: 16 October 2023
Revised Date: 4 February 2024
Accepted Date: 14 February 2024
Available Online: 20 February 2024

Figures(4)

Parkinson’s disease (PD) is an aging-associated neurodegenerative movement disorder with increasing morbidity and mortality rates. The current gold standard for diagnosing PD is clinical evaluation, which is often challenging and inaccurate. Metabolomics and lipidomics approaches have been extensively applied because of their potential in discovering valuable biomarkers for medical diagnostics. Here, we used comprehensive untargeted metabolomics and lipidomics methodologies based on liquid chromatography-mass spectrometry to evaluate metabolic abnormalities linked with PD. Two well-characterized cohorts of 288 plasma samples (143 PD patients and 145 control subjects in total) were used to examine metabolic alterations and identify diagnostic biomarkers. Unbiased multivariate and univariate studies were combined to identify the promising metabolic signatures, based on which the discriminant models for PD were established by integrating multiple machine learning algorithms. A 6-biomarker predictive model was constructed based on the omics profile in the discovery cohort, and the discriminant performance of the biomarker panel was evaluated with an accuracy over 81.6% both in the discovery cohort and validation cohort. The results indicated that PC (40:7), eicosatrienoic acid were negatively correlated with severity of PD, and pentalenic acid, PC (40:6p) and aspartic acid were positively correlated with severity of PD. In summary, we developed a multi-metabolite predictive model which can diagnose PD with over 81.6% accuracy based on this unique metabolic signature. Future clinical diagnosis of PD may benefit from the biomarker panel reported in this study.
- Parkinson’s disease,
- Metabolomics,
- Lipidomics,
- Machine learning,
- Biomarker
1. [1]
  D. Aarsland, L. Batzu, G.M. Halliday, G.J. Geurtsen, et al., Nat. Rev. Dis. Primers 7 (2021) 1–21. doi: 10.1038/s41572-020-00234-1
2. [2]
  K.R. Chaudhuri, N. Titova, Eur. Neurol. Rev. 14 (2019) 28–35. doi: 10.17925/ENR.2019.14.1.28
3. [3]
  D.W. Dickson, Cold Spring Harb. Perspect. Med. 2 (2012).
4. [4]
  G. DeMaagd, A. Philip, Clin. Pharmacol. Ther. 40 (2015) 504. doi: 10.1111/jcpt.12304
5. [5]
  Y. Shao, W. Le, Mol. Neurodegener. 14 (2019) 1–12. doi: 10.1186/s13024-018-0301-5
6. [6]
  L. Parnetti, L. Gaetani, et al., Lancet Neurol. 18 (2019) 573–586. doi: 10.1016/S1474-4422(19)30024-9
7. [7]
  G.A. Nagana Gowda, S. Zhang, H. Gu, et al., Expert Rev. Mol. Diagn. 8 (2008) 617–633. doi: 10.1586/14737159.8.5.617
8. [8]
  S. Gao, X. Zhou, M. Yue, S. Zhu, Q. Liu, X.E. Zhao, Trac-Trend Anal. Chem. 162 (2023) 117022. doi: 10.1016/j.trac.2023.117022
9. [9]
  S.S. Ahmed, W. Santosh, S. Kumar, et al., J. Biomed. Sci. 16 (2009) 63. doi: 10.1186/1423-0127-16-63
10. [10]
  H. Boecker, A.O. Ceballos-Baumann, D. Volk, B. Conrad, H. Forstl, P. Haussermann, Arch. Neurol. 64 (2007) 984–988. doi: 10.1001/archneur.64.7.984
11. [11]
  A. Anandhan, M.S. Jacome, S. Lei, P. Hernandez-Franco, et al., Brain Res. Bull. 133 (2017) 12–30. doi: 10.1016/j.brainresbull.2017.03.009
12. [12]
  E. Socha, M. Koba, P. Kośliński, Amino Acids 51 (2019) 367–371. doi: 10.1007/s00726-019-02705-6
13. [13]
  M. Figura, K. Kuśmierska, E. Bucior, et al., PLoS One 13 (2018) e0191670. doi: 10.1371/journal.pone.0191670
14. [14]
  S.M. Grant, S. Demorrow, Int. J. Mol. Sci. 21 (2020) 1–25.
15. [15]
  P. Li, B.A. Killinger, E. Ensink, et al., Metabolites 11 (2021) 29. doi: 10.3390/metabo11010029
16. [16]
  Y. Hasuike, T. Endo, M. Koroyasu, M. Matsui, et al., Med. Hypotheses 134 (2020) 109436. doi: 10.1016/j.mehy.2019.109436
17. [17]
  Y. Shao, T. Li, Z. Liu, et al., Mol. Neurodegener. 16 (2021) 4. doi: 10.1186/s13024-021-00425-8
18. [18]
  S. Fanning, A. Haque, T. Imberdis, V. Baru, et al., Mol. Cell 73 (2019) 1001–1014.e8. doi: 10.1016/j.molcel.2018.11.028
19. [19]
  H. Avisar, C. Guardia-Laguarta, E. Area-Gomez, et al., J. Parkinsons Dis. 11 (2021) 1141–1155. doi: 10.3233/JPD-202476
20. [20]
  A. Zardini Buzatto, J. Tatlay, B. Bajwa, et al., J. Proteome Res. 20 (2021) 4053–4067. doi: 10.1021/acs.jproteome.1c00374
21. [21]
  E. Sinclair, D.K. Trivedi, D. Sarkar, C. Walton-Doyle, et al., Nat. Commun. 12 (2021) 1–9. doi: 10.1038/s41467-020-20314-w
22. [22]
  F. Moisan, S. Kab, F. Mohamed, M. Canonico, et al., J. Neurol. Neurosurg. Psychiatry 87 (2016) 952–957. doi: 10.1136/jnnp-2015-312283
23. [23]
  E.R. Dorsey, A. Elbaz, E. Nichols, F. Abd-Allah, et al., Lancet Neurol. 17 (2018) 939–953. doi: 10.1016/S1474-4422(18)30295-3
24. [24]
  S. Cui, L. Li, Y. Zhang, et al., Adv. Sci. 8 (2021) 2003893. doi: 10.1002/advs.202003893
25. [25]
  P.S. Gromski, H. Muhamadali, et al., Anal. Chim. Acta 879 (2015) 10–23. doi: 10.1016/j.aca.2015.02.012
26. [26]
  X. Wang, X. Hao, J. Yan, et al., Chin. Chem. Lett. 34 (2023) 108230. doi: 10.1016/j.cclet.2023.108230
27. [27]
  K. Su, J. Wu, D. Gu, S. Yang, et al., Diagnostics 11 (2021) 960944.
28. [28]
  T. Chen, Y. Cao, Y. Zhang, et al., Evid. Based Complementary Altern. Med. 2013 (2013) 298183.
29. [29]
  R. Bujak, E. Daghir-Wojtkowiak, R. Kaliszan, M.J. Markuszewski, Front. Mol. Biosci. 3 (2016) 35.
30. [30]
  S.H. Law, M.L. Chan, G.K. Marathe, et al., Int. J. Mol. Sci. 20 (2019) 1149. doi: 10.3390/ijms20051149
31. [31]
  H.E. Moon, S.H. Paek, Exp. Neurobiol. 24 (2015) 103–116. doi: 10.5607/en.2015.24.2.103
32. [32]
  K.W. Chung, Cells 10 (2021) 880. doi: 10.3390/cells10040880
33. [33]
  S. Fanning, D. Selkoe, U. Dettmer, NPJ Parkinsons Dis. 6 (2020) 1–9. doi: 10.1038/s41531-019-0104-6
34. [34]
  M. Fais, A. Dore, M. Galioto, et al., Int. J. Mol. Sci. 22 (2021) 7630. doi: 10.3390/ijms22147630
35. [35]
  S.T. Tan, T. Ramesh, X.R. Toh, L.N. Nguyen, Prog. Lipid Res. 80 (2020) 101068. doi: 10.1016/j.plipres.2020.101068
36. [36]
  B. Fuchs, J. Schiller, U. Wagner, H. Häntzschel, K. Arnold, Clin. Biochem. 38 (2005) 925–933. doi: 10.1016/j.clinbiochem.2005.06.006
37. [37]
  A. Goonesinghe, E.S. Mundy, M. Smith, et al., Biochem. J. 387 (2005) 109–118. doi: 10.1042/BJ20041389
38. [38]
  J. Miletic Vukajlović, D. Drakulić, S. Pejić, et al., Rapid Commun. Mass Spectrom. 34 (2020) e8595. doi: 10.1002/rcm.8595
39. [39]
  D. Ruiz-Perez, H. Guan, P. Madhivanan, K. Mathee, G. Narasimhan, BMC Bioinform. 21 (2020) 1–10. doi: 10.1186/s12859-019-3325-0
40. [40]
  D. Grissa, M. Pétéra, M. Brandolini, et al., Front. Mol. Biosci. 3 (2016) 30.
1. [1]
  Yao-Hua Gu , Yu Chen , Qing Li , Neng-Bin Xie , Xue Xing , Jun Xiong , Min Hu , Tian-Zhou Li , Ke-Yu Yuan , Yu Liu , Tang Tang , Fan He , Bi-Feng Yuan . Metabolome profiling by widely-targeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of chronic kidney disease. Chinese Chemical Letters, 2024, 35(11): 109627-. doi: 10.1016/j.cclet.2024.109627
2. [2]
  Yuting Wu , Haifeng Lv , Xiaojun Wu . Design of two-dimensional porous covalent organic framework semiconductors for visible-light-driven overall water splitting: A theoretical perspective. Chinese Journal of Structural Chemistry, 2024, 43(11): 100375-100375. doi: 10.1016/j.cjsc.2024.100375
3. [3]
  Yanhua Chen , Xian Ding , Jun Zhou , Zhaoying Wang , Yunhai Bo , Ying Hu , Qingce Zang , Jing Xu , Ruiping Zhang , Jiuming He , Fen Yang , Zeper Abliz . Plasma metabolomics combined with mass spectrometry imaging reveals crosstalk between tumor and plasma in gastric cancer genesis and metastasis. Chinese Chemical Letters, 2025, 36(1): 110351-. doi: 10.1016/j.cclet.2024.110351
4. [4]
  Zixing Xu , Ruiying Chen , Chuanming Hao , Qionghong Xie , Chunhui Deng , Nianrong Sun . Peptidome data-driven comprehensive individualized monitoring of membranous nephropathy with machine learning. Chinese Chemical Letters, 2024, 35(5): 108975-. doi: 10.1016/j.cclet.2023.108975
5. [5]
  Qingyun Hu , Wei Wang , Junyuan Lu , He Zhu , Qi Liu , Yang Ren , Hong Wang , Jian Hui . High-throughput screening of high energy density LiMn_1-xFe_xPO₄ via active learning. Chinese Chemical Letters, 2025, 36(2): 110344-. doi: 10.1016/j.cclet.2024.110344
6. [6]
  Cheng Guo , Xiaoxiao Zhang , Xiujuan Hong , Yiqiu Hu , Lingna Mao , Kezhi Jiang . Graphene as adsorbent for highly efficient extraction of modified nucleosides in urine prior to liquid chromatography-tandem mass spectrometry analysis. Chinese Chemical Letters, 2024, 35(4): 108867-. doi: 10.1016/j.cclet.2023.108867
7. [7]
  Chengde Wang , Liping Huang , Shanshan Wang , Lihao Wu , Yi Wang , Jun Dong . A distinction of gliomas at cellular and tissue level by surface-enhanced Raman scattering spectroscopy. Chinese Chemical Letters, 2024, 35(5): 109383-. doi: 10.1016/j.cclet.2023.109383
8. [8]
  Ze Zhang , Lei Yang , Jin-Ru Liu , Hao Hu , Jian-Li Mi , Chao Su , Bei-Bei Xiao , Zhi-Min Ao . Improved oxygen electrocatalysis at FeN₄ and CoN₄ sites via construction of axial coordination. Chinese Chemical Letters, 2025, 36(2): 110013-. doi: 10.1016/j.cclet.2024.110013
9. [9]
  Aolei Tan , Xiaoxiao Ma . Exploring the functional roles of small-molecule metabolites in disease research: Recent advancements in metabolomics. Chinese Chemical Letters, 2024, 35(8): 109276-. doi: 10.1016/j.cclet.2023.109276
10. [10]
  Yiwen Lin , Yijie Chen , Chunhui Deng , Nianrong Sun . Integration of resol/block-copolymer carbonization and machine learning: A convenient approach for precise monitoring of glycan-associated disorders. Chinese Chemical Letters, 2024, 35(12): 109813-. doi: 10.1016/j.cclet.2024.109813
11. [11]
  Xiaochen Zhang , Fei Yu , Jie Ma . 多角度数理模拟在电容去离子中的前沿应用. Acta Physico-Chimica Sinica, 2024, 40(11): 2311026-. doi: 10.3866/PKU.WHXB202311026
12. [12]
  Jia Zhou . Constructing Potential Energy Surface of Water Molecule by Quantum Chemistry and Machine Learning: Introduction to a Comprehensive Computational Chemistry Experiment. University Chemistry, 2024, 39(3): 351-358. doi: 10.3866/PKU.DXHX202309060
13. [13]
  Xinghai Li , Zhisen Wu , Lijing Zhang , Shengyang Tao . Machine Learning Enables the Prediction of Amide Bond Synthesis Based on Small Datasets. Acta Physico-Chimica Sinica, 2025, 41(2): 100010-. doi: 10.3866/PKU.WHXB202309041
14. [14]
  Junmeng Luo , Qiongqiong Wan , Suming Chen . Chemistry-driven mass spectrometry for structural lipidomics at the C=C bond isomer level. Chinese Chemical Letters, 2025, 36(1): 109836-. doi: 10.1016/j.cclet.2024.109836
15. [15]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
16. [16]
  Jingting Wang , Yuanyuan Chen , Linlin Han , Shasha Xia , Xingyao Zhang , Peng Xue , Yuejun Kang , Jian Ming , Zhigang Xu . Microenvironment responsive pod-structured astaxanthin nanocarrier for ameliorating inflammatory bowel disease. Chinese Chemical Letters, 2024, 35(7): 109029-. doi: 10.1016/j.cclet.2023.109029
17. [17]
  Zhe-Han Yang , Jie Yin , Lei Xin , Yuanfang Li , Yijie Huang , Ruo Yuan , Ying Zhuo . Research advancement of DNA-based intelligent hydrogels: Manufacture, characteristics, application of disease diagnosis and treatment. Chinese Chemical Letters, 2024, 35(10): 109558-. doi: 10.1016/j.cclet.2024.109558
18. [18]
  Guoju Guo , Xufeng Li , Jie Ma , Yongjia Shi , Jian Lv , Daoshan Yang . Photocatalyst/metal-free sequential C–N/C–S bond formation: Synthesis of S-arylisothioureas via photoinduced EDA complex activation. Chinese Chemical Letters, 2024, 35(11): 110024-. doi: 10.1016/j.cclet.2024.110024
19. [19]
  Hao GUO , Tong WEI , Qingqing SHEN , Anqi HONG , Zeting DENG , Zheng FANG , Jichao SHI , Renhong LI . Electrocatalytic decoupling of urea solution for hydrogen production by nickel foam-supported Co₉S₈/Ni₃S₂ heterojunction. Chinese Journal of Inorganic Chemistry, 2024, 40(11): 2141-2154. doi: 10.11862/CJIC.20240085
20. [20]
  Qiang Zhang , Weiran Gong , Huinan Che , Bin Liu , Yanhui Ao . S doping induces to promoted spatial separation of charge carriers on carbon nitride for efficiently photocatalytic degradation of atrazine. Chinese Journal of Structural Chemistry, 2023, 42(12): 100205-100205. doi: 10.1016/j.cjsc.2023.100205

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(150)
HTML views(4)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142